Cell and Gene Therapy Manufacturing QC Market: Strategic Insights, Opportunities, Statistics by 2033

Comentários · 1 Visualizações

According to Straits Research, the global Cell and Gene Therapy Manufacturing QC Market size was valued at USD 2.24 Billion in 2024. It is projected to grow from USD 2.82 Billion in 2025 to USD 17.55 Billion by 2033, with a projected CAGR of 25.7% over the forecast period (2025–2033).

 The Global Cell and Gene Therapy Manufacturing QC Market Report presents an in-depth analysis, merging qualitative and quantitative insights to provide a holistic understanding of the market's dynamics. The report evaluates growth drivers, challenges, and constraints while forecasting revenue trends across key segments. It offers both historical and projected data, giving stakeholders a clear view of market trends and future potential.

According to Straits Research, the global Cell and Gene Therapy Manufacturing QC Market size was valued at USD 2.24 Billion in 2024. It is projected to grow from USD 2.82 Billion in 2025 to USD 17.55 Billion by 2033, with a projected CAGR of 25.7% over the forecast period (2025–2033).

This report dives into the competitive landscape, featuring key market players, including their marketing strategies, revenue shares, recent advancements, and roles in shaping the industry. The report details major players' profiles and includes information on mergers and acquisitions, industry concentration ratios, and new trends influenced by COVID-19 and global regional conflicts. Such insights help readers understand competitors' positioning and provide strategies for market entry and expansion.

Cell and Gene Therapy Manufacturing QC Market Insight Values:

Report AttributeDetails
No. of Pages110
Forecast Period2025-2033
Estimated Market Value (USD) in 2024USD 2.24 Billion
Forecasted Market Value (USD) by 2033USD 17.55 Billion
Compound Annual Growth Rate25.7%
Regions CoveredGlobal

Download Free Sample Report with Complimentary Analyst Consultation: https://straitsresearch.com/report/cell-and-gene-therapy-manufacturing-qc-market/request-sample

Cell and Gene Therapy Manufacturing QC Market Report Highlights

  • Market Overview and Segmentation: Provides a macro and micro-level analysis of market size, industry chain, and market dynamics, covering segmentation by type, application, and region.
  • Comprehensive Regional Analysis: Offers detailed forecasts and analysis for regions, including North America (U.S., Canada), Europe (U.K., Germany, France, Italy), Asia Pacific (China, India, Japan, Singapore, Malaysia), Latin America (Brazil, Mexico), and the Middle East & Africa.
  • Competitive Landscape: Highlights key players' profiles with information on market share, revenue, and growth strategies. Covers publicly listed and privately held companies, with insights into regional marketing and operational strategies.
  • Emerging Trends and Opportunities: Discusses recent developments, market expansion strategies, and identifies potential growth areas across regions and segments.
  • Industry Challenges and Risk Analysis: Addresses key risks, market constraints, production costs, raw material availability, and methods to mitigate these challenges.

Cell and Gene Therapy Manufacturing QC Market Top Players

The report provides a comprehensive view of the competitive landscape within the Cell and Gene Therapy Manufacturing QC Market, profiling key players and analyzing their market impact. These companies, including 

  1. WuXi AppTec
  2. Lonza
  3. Thermo Fisher Scientific
  4. Charles River Laboratories
  5. Catalent
  6. Merck KGaA
  7. Eurofins Scientific
  8. Pace
  9. Pharmaron
  10. BioAgilytix Labs
  11. Avance Biosciences
  12. SGS
  13. IQVIA
  14. Alcami Corporation
  15. Solvias
  16. Pacific BioLabs
  17. ProtaGene
  18. Laboratory Corporation of America Holdings
  19. AGC Biologics
  20. uBriGene Biosciences International Co.

Cell and Gene Therapy Manufacturing QC Market Market Segmentation

  1. By Therapy Type
    1. Cell Therapy
      1. CAR-T
        1. Autologous CAR-T
        2. Allogeneic CAR-T
      2. CAR-NK
      3. B-Cell
      4. Others
    2. Gene Therapy
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Other
      2. Non-Viral
  2. By Scale
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. By Mode
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. By Workflow
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. By Process
    1. Upstream Processes
    2. Downstream Processes
  6. By End-User
    1. Pharmaceutical Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    2. Biopharmaceutical / Biotechnological Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    3. Contract Manufacturing Organizations
      1. Small Size
      2. Medium Size
      3. Large Size
  7. By Technology Type
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others

 

Market Segmentation: https://straitsresearch.com/report/cell-and-gene-therapy-manufacturing-qc-market/segmentation

FAQs Addressed in the Cell and Gene Therapy Manufacturing QC Market Research Report:

  • What recent brand-building initiatives have key players undertaken to enhance customer value in the Cell and Gene Therapy Manufacturing QC Market?
  • Which companies have broadened their focus through long-term societal initiatives?
  • How have firms successfully navigated the pandemic, and what strategies have they adopted to remain resilient?
  • What are the global trends in the Cell and Gene Therapy Manufacturing QC Market, and will demand increase or decrease in the coming years?
  • Where will strategic developments lead the industry in the mid to long term?
  • What factors influence the final price of absorption cooling devices, and what raw materials are utilized in their manufacturing?
  • How significant is the growth opportunity for the Cell and Gene Therapy Manufacturing QC Market, and how will increasing adoption in mining affect the market's growth rate?
  • What recent industry trends can be leveraged to create additional revenue streams?

Scope of the Report:

  • Impact of COVID-19: Analyzes both immediate and long-term effects of the pandemic on the industry.
  • Industry Chain Analysis: Examines disruptions to the industry chain and changes in marketing channels.
  • Impact of the Middle East Crisis: Assesses the ongoing Middle East crisis's influence on industry stability, supply chains, and market trends.

Buy Full Report (Exclusive Insights): https://straitsresearch.com/buy-now/cell-and-gene-therapy-manufacturing-qc-market

About Straits Research

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Contact Us:

Comentários